Targeted radionuclide therapy in patient-derived xenografts using (177)Lu-EB-RGD

Currently, most patients with non-small cell lung cancer (NSCLC) are diagnosed in advanced stages with a poor five-year survival rate. Therefore, intensive research aimed at finding novel therapeutic strategies has been ongoing; experimental models that reliably emulate NSCLC disease are greatly nee...

詳細記述

保存先:
書誌詳細
出版年:Mol Cancer Ther
主要な著者: Zhao, Liang, Chen, Haojun, Guo, Zhide, Fu, Kaili, Yao, Lanling, Fu, Li, Guo, Weixi, Wen, Xuejun, Jacobson, Orit, Zhang, Xianzhong, Sun, Long, Wu, Hua, Lin, Qin, Chen, Xiaoyuan
フォーマット: Artigo
言語:Inglês
出版事項: 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541553/
https://ncbi.nlm.nih.gov/pubmed/32847972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-19-1098
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料